[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 21",
    "summary": "This is our weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest in the article series here.",
    "url": "https://finnhub.io/api/news?id=5f623d6b6171fb1275bbe4fef41c4cb5cf50ccda63dc6337f12605fc6855b5c4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758306089,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 21",
      "id": 136822784,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "This is our weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest in the article series here.",
      "url": "https://finnhub.io/api/news?id=5f623d6b6171fb1275bbe4fef41c4cb5cf50ccda63dc6337f12605fc6855b5c4"
    }
  },
  {
    "ts": null,
    "headline": "Apple, Amgen share gains contribute to Dow's 118-point jump",
    "summary": "Apple, Amgen share gains contribute to Dow's 118-point jump",
    "url": "https://finnhub.io/api/news?id=00aacf4e165888e38438e9153592f07644b1a3a185a76a0cf2d17bc30994a5e8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758275520,
      "headline": "Apple, Amgen share gains contribute to Dow's 118-point jump",
      "id": 136867515,
      "image": "",
      "related": "UNH",
      "source": "MarketWatch",
      "summary": "Apple, Amgen share gains contribute to Dow's 118-point jump",
      "url": "https://finnhub.io/api/news?id=00aacf4e165888e38438e9153592f07644b1a3a185a76a0cf2d17bc30994a5e8"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth: This Rally Is Lacking Substance; Sell Now",
    "summary": "UNH faces margin pressure from rising medical cost ratios, regulatory limits, DOJ probes, and overvaluation concerns. Click here to find out why UNH is a Sell.",
    "url": "https://finnhub.io/api/news?id=0fe4547bf34df01ca1d4ee9131c7a950cbc92869e46940152a7fd73a9d0b92b2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758272394,
      "headline": "UnitedHealth: This Rally Is Lacking Substance; Sell Now",
      "id": 136817736,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1022820984/image_1022820984.jpg?io=getty-c-w1536",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "UNH faces margin pressure from rising medical cost ratios, regulatory limits, DOJ probes, and overvaluation concerns. Click here to find out why UNH is a Sell.",
      "url": "https://finnhub.io/api/news?id=0fe4547bf34df01ca1d4ee9131c7a950cbc92869e46940152a7fd73a9d0b92b2"
    }
  }
]